Editorial
Copyright ©The Author(s) 2019.
World J Psychiatr. Jun 10, 2019; 9(3): 47-54
Published online Jun 10, 2019. doi: 10.5498/wjp.v9.i3.47
Table 2 Summary of studies
Name of studyYrCountry of originTotal number of participantsAgeType of settingComparatorsDuration
Meltzer et al[23]2010United States60Mean age 70.9 yrUnclearPimavanserin vs placebo4 wk
Cummings et al[24]2014United States and Canada199Mean age 72.4 yrAcademic hospitals and neurology research centersPimavanserin vs placebo6 wk